Table 3. Direct medical costs estimated in CLP of December 2017 and U$D*.
| Disease events (annual) | Cost CLP | Cost U$D | Method/source |
|---|---|---|---|
| Acute myocardial infarction (AMI) | 3,015,985 | 4,645 | AUGE- FONASA study |
| Non-AMI ischemic event | 2,065,883 | 3,182 | AUGE–FONASA study |
| CHD follow-up (annual) | 1,104,263 | 1,701 | AUGE–FONASA study—Delphi |
| Stroke | 3,388,256 | 5,218 | AUGE–FONASA study |
| Stroke follow-up (annual) | 1,163,564 | 1,792 | AUGE—FONASA—Delphi |
| Pneumonia/influenza | 179,618 | 277 | AUGE—FONASA |
| Mild COPD (annual) | 191,223 | 294 | Microcosting & OS |
| Moderate COPD (annual) | 422,257 | 650 | Microcosting & OS |
| Severe COPD (annual) | 4,689,113 | 7,221 | AUGE—FONASA–OS |
| Lung cancer 1st year | 16,613,003 | 25,585 | Cost-Effectiveness Study |
| Lung cancer 2nd year | 21,480,916 | 33,082 | CE Study & Delphi |
| Mouth cancer 1st year | 11,961,362 | 18,421 | Costing based on the proportions to lung cancer, as found in Delphi exercise in Argentina |
| Mouth cancer - 2nd year onwards | 8,162,748 | 12,571 | |
| Esophageal cancer 1st year | 13,954,922 | 21,491 | |
| Esophageal cancer - 2nd year onwards | 9,451,603 | 14,556 | |
| Stomach cancer 1st year | 13,622,662 | 20,980 | |
| Stomach cancer - 2nd year onwards | 10,310,840 | 15,879 | |
| Pancreatic cancer 1st year | 11,296,842 | 17,398 | |
| Pancreatic cancer - 2nd year onwards | 7,733,130 | 11,909 | |
| Kidney cancer 1st year | 11,961,362 | 18,421 | |
| Kidney cancer - 2nd year onwards | 8,377,557 | 12,902 | |
| Laryngeal cancer 1st year | 13,622,662 | 20,980 | |
| Laryngeal cancer - 2nd year onwards | 9,881,221 | 15,218 | |
| Leukemia 1st year | 17,942,043 | 27,632 | |
| Leukemia - 2nd year onwards | 20,621,679 | 31,758 | |
| Bladder cancer 1st year | 11,296,842 | 17,398 | |
| Bladder cancer - 2nd year onwards | 10,310,840 | 15,879 | |
| Cervical cancer 1st year | 10,300,062 | 15,863 | |
| Cervical cancer - 2nd year onwards | 5,578,040 | 8,590 |
AUGE: national program of explicit guaranties in health, COPD: chronic obstructive pulmonary disease, CHD: coronary heart disease, FONASA: National Health Fund, OS: Other sources
*Exchange rate per dollar is the 2017 observed mean value, published by the Chilean Central Bank: 649,33 CLP.